HROW vs. RWL

Last updated Jun 4, 2026

HROW (Harrow Health, Inc.) is a stock, while RWL (Invesco S&P 500 Revenue ETF) is S&P 500 fund tracking the S&P 500 Revenue-Weighted Index. Over the past 10 years, HROW returned 23.55%/yr vs 13.96%/yr for RWL. At a 0.16 correlation, their price movements are largely independent.

Performance

HROW vs. RWL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harrow Health, Inc. (HROW) and Invesco S&P 500 Revenue ETF (RWL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HROW achieves a -32.00% return, which is significantly lower than RWL's 11.07% return. Over the past 10 years, HROW has outperformed RWL with an annualized return of 23.55%, while RWL has yielded a comparatively lower 13.96% annualized return.

HROW

• 1D: 1.40%
• 1M: -17.11%
• YTD: -32.00%
• 6M: -25.16%
• 1Y: 13.57%
• 3Y*: 19.43%
• 5Y*: 29.87%
• 10Y*: 23.55%

RWL

• 1D: -0.42%
• 1M: 3.13%
• YTD: 11.07%
• 6M: 11.66%
• 1Y: 26.76%
• 3Y*: 19.96%
• 5Y*: 12.89%
• 10Y*: 13.96%

*Multi-year figures are annualized to reflect compound growth (CAGR)

HROW vs. RWL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
HROW Harrow Health, Inc.	-32.00%	46.05%	199.55%	-24.12%	70.83%	25.95%	-11.83%	36.73%	234.71%	-32.00%
RWL Invesco S&P 500 Revenue ETF	11.07%	18.65%	16.45%	17.43%	-6.00%	30.29%	9.14%	27.83%	-7.74%	20.34%

Correlation

The correlation between HROW and RWL is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.46
Correlation (3Y) Calculated over the trailing 3-year period	0.39
Correlation (5Y) Calculated over the trailing 5-year period	0.33
Correlation (10Y) Calculated over the trailing 10-year period	0.28
Correlation (All Time) Calculated using the full available price history since Feb 25, 2008	0.16

Over the past year, HROW and RWL have become more correlated (0.46) than their long-term average of 0.16, meaning their price movements have been converging.

Return for Risk

HROW vs. RWL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HROW

HROW Risk / Return Rank: 48
HROW Sharpe Ratio Rank: 48
HROW Sortino Ratio Rank: 47
HROW Omega Ratio Rank: 49
HROW Calmar Ratio Rank: 47
HROW Martin Ratio Rank: 48

RWL

RWL Risk / Return Rank: 81
RWL Sharpe Ratio Rank: 81
RWL Sortino Ratio Rank: 82
RWL Omega Ratio Rank: 79
RWL Calmar Ratio Rank: 78
RWL Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HROW vs. RWL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Harrow Health, Inc. (HROW) and Invesco S&P 500 Revenue ETF (RWL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HROW	RWL	Difference
Sharpe ratio Return per unit of total volatility	0.21	2.69	-2.48
Sortino ratio Return per unit of downside risk	0.72	3.76	-3.04
Omega ratio Gain probability vs. loss probability	1.11	1.48	-0.37
Calmar ratio Return relative to maximum drawdown	0.29	4.05	-3.76
Martin ratio Return relative to average drawdown	0.66	17.12	-16.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HROW vs. RWL - Sharpe Ratio Comparison

The current HROW Sharpe Ratio is 0.21, which is lower than the RWL Sharpe Ratio of 2.69. The chart below compares the historical Sharpe Ratios of HROW and RWL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	HROW	RWL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.21	2.69	-2.48
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.43	0.89	-0.46
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.33	0.83	-0.50
Sharpe Ratio (All Time) Calculated using the full available price history	-0.05	0.58	-0.62

Drawdowns

HROW vs. RWL - Drawdown Comparison

The maximum HROW drawdown since its inception was -99.46%, which is greater than RWL's maximum drawdown of -54.83%. Use the drawdown chart below to compare losses from any high point for HROW and RWL.

Drawdown Indicators

	HROW	RWL	Difference
Max Drawdown Largest peak-to-trough decline	-99.46%	-54.83%	-44.63%
Max Drawdown (1Y) Largest decline over 1 year	-47.03%	-6.64%	-40.39%
Max Drawdown (3Y) Largest decline over 3 years	-63.32%	-14.39%	-48.93%
Max Drawdown (5Y) Largest decline over 5 years	-71.15%	-17.49%	-53.66%
Max Drawdown (10Y) Largest decline over 10 years	-71.15%	-36.04%	-35.11%
Current Drawdown Current decline from peak	-75.86%	-0.57%	-75.29%
Average Drawdown Average peak-to-trough decline	-86.74%	-6.45%	-80.29%
Ulcer Index Depth and duration of drawdowns from previous peaks	20.50%	1.57%	+18.93%

Volatility

HROW vs. RWL - Volatility Comparison

Harrow Health, Inc. (HROW) has a higher volatility of 29.71% compared to Invesco S&P 500 Revenue ETF (RWL) at 2.12%. This indicates that HROW's price experiences larger fluctuations and is considered to be riskier than RWL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HROW	RWL	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.71%	2.12%	+27.59%
Volatility (6M) Calculated over the trailing 6-month period	55.43%	7.12%	+48.31%
Volatility (1Y) Calculated over the trailing 1-year period	64.81%	10.00%	+54.81%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	69.96%	14.50%	+55.46%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	71.13%	16.86%	+54.27%

Dividends

HROW vs. RWL - Dividend Comparison

HROW has not paid dividends to shareholders, while RWL's dividend yield for the trailing twelve months is around 1.25%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HROW Harrow Health, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
RWL Invesco S&P 500 Revenue ETF	1.25%	1.35%	1.43%	1.60%	1.62%	1.35%	1.75%	1.87%	1.99%	1.60%	1.71%	1.97%

Frequently Asked Questions

Can I hold both HROW and RWL in my portfolio?

HROW and RWL have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HROW or RWL?

HROW has higher volatility (29.71%) compared to RWL (2.12%). In terms of maximum drawdown, HROW dropped -99.46% vs RWL's -54.83%.

Which has better risk-adjusted returns?

RWL currently has the higher Sharpe Ratio (2.69 vs 0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.